Pharmaceutical dosages delivery system

a technology of dosages and pharmaceuticals, applied in the field of electronic devices, can solve the problems of large number of hospitalizations and admissions to nursing homes every year, and high cost of patients who do not comply with prescribed medication regimens. it is estimated that the cost of non-adherence to medication is over $100 billion annually

Active Publication Date: 2013-12-03
PROTEUS DIGITAL HEALTH INC
View PDF824 Cites 80 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0066]Performing clinical trials with pharmaceutical dosages prepared according to the invention provides a number of advantages. One advantage is that the clinical trial manager (the entity who is running the clinical trial) can use standard carrier components and caps and customize these as needed with a given pharmaceutically active agent composition.

Problems solved by technology

However, studies show that on average, about 50% of patients do not comply with prescribed medication regimens.
A low rate of adherence with medication regimens results in a large number of hospitalizations and admissions to nursing homes every year.
In the United States alone, it has recently been estimated that costs resulting from patient non-adherence amount to over $100 billion annually.
Such an elevated dose could cause a higher incidence of side effects, which in turn may lead to further non-adherence.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical dosages delivery system
  • Pharmaceutical dosages delivery system
  • Pharmaceutical dosages delivery system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0017]Devices of the invention include a carrier component and a cap configured to seal an internal volume of the carrier component, where the cap includes an ingestible event marker identifier. Devices of invention find use in preparing a pharmaceutical dosage. Additional aspects of the invention include dosages prepared in accordance with the methods of the invention. Dosages prepared according to various aspects of the invention find use in a variety of different applications, including clinical trials.

[0018]In describing the invention in greater detail, devices of the invention and methods for their use in preparing a pharmaceutical dosage are reviewed first, followed by a discussion of the utility of such methods, and assemblies and systems involving the same. Also reviewed in greater detail below are kits for practicing methods of the invention.

[0019]As summarized above, devices and methods for their use in preparing pharmaceutical dosages are provided. The term “pharmaceutica...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Pharmaceutical delivery systems for delivering dosages according to the present invention include a carrier component and a cap configured to seal an internal volume of the carrier component, wherein the cap includes a device that produces a unique current signature. Dosages prepared to be delivered according to embodiments of the invention find use in a variety of different applications, including clinical trials.

Description

CROSS-REFERENCE[0001]Pursuant to 35 U.S.C. §119 (e), this application claims priority to the filing date of U.S. Provisional Patent Application Ser. No. 61 / 142,861 filed on Jan. 6, 2009, the disclosure of which application is herein incorporated by reference. This application also claims the benefit of PCT Application No. PCT / US10 / 20140 of the same title filed on Jan. 5, 2010, which is herein incorporated by reference.FIELD OF THE INVENTION[0002]This invention relates generally to electronic devices and, more specifically, to electronic devices that are part of a communication system that uses conduction to communicate information.INTRODUCTION[0003]Prescription medications are effective remedies for many patients when taken properly. However, studies show that on average, about 50% of patients do not comply with prescribed medication regimens. A low rate of adherence with medication regimens results in a large number of hospitalizations and admissions to nursing homes every year. In...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(United States)
IPC IPC(8): A61B5/07
CPCA61B5/1473A61B5/4839A61M31/00A61M31/002A61B5/07A61K9/0097A61J3/071
Inventor HAFEZI, HOOMANMOON, GREGORYAU-YEUNG, KITYEEDUCK, ROBERTHOLEN, MARIA CASILLAS
Owner PROTEUS DIGITAL HEALTH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products